The Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP STUDY)
Phase of Trial: Phase II
Latest Information Update: 17 Apr 2017
At a glance
- Drugs Caffeine citrate (Primary) ; Ibuprofen (Primary) ; Ketorolac (Primary)
- Indications Retinopathy of prematurity
- Focus Therapeutic Use
- Acronyms SPIPROP study
- 10 Apr 2017 Planned End Date changed from 1 Dec 2016 to 30 Jun 2017.
- 10 Apr 2017 Planned primary completion date changed from 1 Dec 2016 to 30 Jun 2017.
- 31 Jan 2015 New trial record